| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.26 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |